• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
Friends

Generous Philanthropic Gift Will Name the UCLA Division of Digestive Diseases

  Vatche and Tamar Manoukian  
 

Vatche and Tamar Manoukian
Photo: Courtesy of Tamar and Vatche Manoukian

Building on their previous philanthropy to UCLA, Tamar and Vatche Manoukian have made a landmark gift to the Division of Digestive Diseases at the David Geffen School of Medicine at UCLA that will provide unrestricted funds to accelerate research, innovative clinical care and educational priorities. This generous effort has inspired additional anonymous pledged support, bringing the total of the gift on behalf of the Manoukians to $30 million to benefit the division and crucial initiatives in the David Geffen School of Medicine at UCLA. In recognition of the Manoukians’ leadership philanthropy, the university will name the division in their honor, making this the first division naming in the David Geffen School of Medicine at UCLA. In addition to the UCLA Vatche and Tamar Manoukian Division of Digestive Diseases, the university has named 100 UCLA Medical Plaza the Vatche and Tamar Manoukian Medical Building.

“Visionary philanthropy can alter the course of science,” said Dr. John C. Mazziotta (RES ’81, FEL ’83), vice chancellor for UCLA Health Sciences and CEO of UCLA Health. “The remarkable generosity of Tamar and Vatche Manoukian will be instrumental in positioning the division for the future.”

“It is Tamar’s and my hope that our gift will not only change medical science, but also will be a model for others,” Manoukian said. “We hope it will inspire young people to give and to become engaged with causes that matter.”

A leader in the Armenian community, Vatche Manoukian has been involved in a wide range of businesses, including property investment, retail, pharmaceuticals, biotechnology, entertainment and renewable energy. He and his wife, who have four children, have continued his family’s tradition of charitable work throughout the world, with a particular emphasis on education, medicine, culture, the environment and Armenian causes. The Manoukians’ scholarship funds have enabled several thousand students who lacked financial resources to further their education, and postgraduate programs established by the Manoukians at universities in the United States, the United Kingdom and Lebanon have helped provide essential skills for tomorrow’s community leaders. The couple also support many children’s charities around the world, including the U.S. Fund for UNICEF, on whose board Vatche Manoukian serves.

“Tamar and Vatche’s exceptional philanthropy will help ensure that UCLA can continue to unravel the mysteries of digestive diseases, make transformative scientific discoveries and develop the physician leaders of the future,” said Dr. Eric Esrailian (FEL ’06), co-chief of the Division of Digestive Diseases and Lincy Foundation Chair in Clinical Gastroenterology in the David Geffen School of Medicine at UCLA.

The UCLA Vatche and Tamar Manoukian Division of Digestive Diseases is renowned for its comprehensive research. Ranked No. 5 in the nation by the U.S. News & World Report 2016-2017 survey, the division has become a model for coordinated care that empowers patients and improves their lives.

For more information, contact Laurel Zeno at: (310) 825-1980

 


Previous
Like Father, Like Son
Next
Cancer Moonshot Summit Aspires to Eclipse Cancer


YOU ARE VIEWING

Fall 2016

Fall 2016
E-Brochure
Printable PDF
IN THIS ISSUE
  • Brave New World
  • A Humble Leader
  • Impaired Decision-making May Contribute to Parkinson’s Motor Symptoms
  • Biomarkers Could Give Cancer Patients Better Survival Estimates
  • UCLA Researchers Grow 3D Lung-in-a-dish
  • UCLA Scientists Advance Cancer-screening Technology to Personalize Treatment
  • Heart-failure Therapy Could Reduce Deaths
  • Fructose Alters Brain Genes, Can Lead to Disease
  • New Method to Study Mitochondrial DNA Diseases
  • Potential Treatment Breakthrough for Advanced Brain Cancer
  • UCLA, Danish Researchers Explain How Eliminating HIV Is Possible
  • Eye on the Future
  • The Collaborator
  • Lonely Planet
  • Bridging the Cultural Divide
  • Heart to Heart
  • Awards & Honors
  • In Memoriam
  • The Long Road from California to the CDC
  • Like Father, Like Son
  • Generous Philanthropic Gift Will Name the UCLA Division of Digestive Diseases
  • Cancer Moonshot Summit Aspires to Eclipse Cancer
  • Kaleidoscopic Circus Celebration Raises Money for Children’s Research
  • Who Cares About the Next Generation
  • Cancer Crusader Establishes Women’s Cancer-research Fund
  • Longtime UCLA Benefactor Expands Commitment to Alzheimer’s Care
  • Symposium on Teen Self-image
  • Medical School Alumni Reunite and Tour Geffen Hall
  • Heart Talk: Women’s Heart Health Program Reaches Out to the Community
  • UCLA Medical Center Boards Welcome New Leadership
  • Gifts
  • ACT III
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth